Name Akansha Chauhan

Division B
Roll no. 11
PRN 21020441025
 Select a company of your choice. Analyse the Profit and Loss Account of the company by creating a comparative chart for la
Compare the Profit and Loss Account of this company with any other company in the same sector by creating a comparative
Find the peers of the selected company and identify the Rank of the company with respect to Last Price, Sales Turnover, Pro
ting a comparative chart for last five years.
tor by creating a comparative chart of both the companies.
Last Price, Sales Turnover, Profit and Assets.
 Dr. Reddy's Laboratories
PROFIT & LOSS ACCOUNT OF DR REDDYS LABORATORIES (in Rs. Cr.) Mar/2021 Mar/2020

INCOME
REVENUE FROM OPERATIONS [GROSS] 11,803.00 10,572.90
Less: Excise/Sevice Tax/Other Levies 0 0
REVENUE FROM OPERATIONS [NET] 11,803.00 10,572.90
TOTAL OPERATING REVENUES 11,850.40 10,625.50
Other Income 743.2 238.4
TOTAL REVENUE 12,593.60 10,863.90
EXPENSES
Cost Of Materials Consumed 2,556.50 2,103.20
Operating And Direct Expenses 0 0
Changes In Inventories Of FG,WIP And Stock-In Trade -99.9 66
Employee Benefit Expenses 2,030.20 1,931.90
Finance Costs 47.8 56.8
Depreciation And Amortisation Expenses 789.2 780.6
Other Expenses 3,376.80 3,356.10
TOTAL EXPENSES 9,817.80 9,163.20
PROFIT/LOSS BEFORE EXCEPTIONAL, EXTRAORDINARY ITEMS AND TAX 2,775.80 1,700.70
Exceptional Items 0 0
PROFIT/LOSS BEFORE TAX 2,775.80 1,700.70
TAX EXPENSES-CONTINUED OPERATIONS
Current Tax 483.9 281.8
Less: MAT Credit Entitlement 0 0
Deferred Tax -645.8 141.6
Tax For Earlier Years 0 0
TOTAL TAX EXPENSES -161.9 423.4
PROFIT/LOSS AFTER TAX AND BEFORE EXTRAORDINARY ITEMS 2,937.70 1,277.30
PROFIT/LOSS FROM CONTINUING OPERATIONS 2,937.70 1,277.30
PROFIT/LOSS FOR THE PERIOD 2,937.70 1,277.30
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.) 177.23 76.98
Diluted EPS (Rs.) 176.88 76.85
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS
Imported Raw Materials 0 0
Indigenous Raw Materials 0 0
STORES, SPARES AND LOOSE TOOLS
Imported Stores And Spares 0 0
Indigenous Stores And Spares 0 0
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend 391.4 332
Tax On Dividend 0 68.2
Equity Dividend Rate (%) 500 400
s
Mar/2019 Mar/2018 Mar/2017

9,302.60 9,628.10 10,234.80 Dr. Reddy's Laboratories Revenue Vs Profit for the
0 0 84.2 14,000.00
9,302.60 9,628.10 10,150.60
9,359.30 9,719.80 10,207.70
12,000.00
204 591.2 244.8
9,563.30 10,311.00 10,452.50
10,000.00

2,011.00 1,904.60 1,988.50

0 0 94.2 8,000.00
In Rs. Cr.

-51.6 1.9 -28.8

1,843.00 1,803.30 1,710.00 6,000.00
62.8 57.2 63.8
774.1 735.1 649.1 4,000.00
3,555.40 3,592.90 3,429.40
8,866.30 8,766.50 8,516.60 2,000.00
697 1,544.50 1,935.90
0 0 -355.9 0.00
697 1,544.50 1,580.00 Mar/2021 Mar/2020 Mar/2019 Mar/2018 Ma

138.1 182.6 416

0 0 97
-8 -22.2 -93.5
0 0 0
130.1 160.4 225.5
566.9 1,384.10 1,354.50
566.9 1,384.10 1,354.50
566.9 1,384.10 1,354.50

34.19 83.05 79.42

34.12 82.88 79.14

0 0 766.8
0 0 1,221.70

0 0 107
0 0 322.1

399.2 335.3 340.5

0 0 69.3
400 400 400
Vs Profit for the year

Mar/2018 Mar/2017
 Dr. Reddy's Laboratories
PROFIT & LOSS ACCOUNT OF DR REDDYS LABORATORIES (in Rs. Cr.) Mar/2021

INCOME
REVENUE - Dr. Reddy's Laboratories 11,803.00
Less: Excise/Sevice Tax/Other Levies 0
REVENUE FROM OPERATIONS [NET] 11,803.00
TOTAL OPERATING REVENUES 11,850.40
Other Income 743.2
TOTAL REVENUE 12,593.60
EXPENSES
Cost Of Materials Consumed 2,556.50
Operating And Direct Expenses 0
Changes In Inventories Of FG,WIP And Stock-In Trade -99.9
Employee Benefit Expenses 2,030.20
Finance Costs 47.8
Depreciation And Amortisation Expenses 789.2
Other Expenses 3,376.80
TOTAL EXPENSES 9,817.80
PROFIT/LOSS BEFORE EXCEPTIONAL, EXTRAORDINARY ITEMS AND TAX 2,775.80
Exceptional Items 0
PROFIT/LOSS BEFORE TAX 2,775.80
TAX EXPENSES-CONTINUED OPERATIONS
Current Tax 483.9
Less: MAT Credit Entitlement 0
Deferred Tax -645.8
Tax For Earlier Years 0
TOTAL TAX EXPENSES -161.9
PROFIT/LOSS AFTER TAX AND BEFORE EXTRAORDINARY ITEMS 2,937.70
PROFIT/LOSS FROM CONTINUING OPERATIONS 2,937.70
PROFIT - Dr. Reddy's Laboratories 2,937.70
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.) 177.23
Diluted EPS (Rs.) 176.88
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES
AND LOOSE TOOLS
Imported Raw Materials 0
Indigenous Raw Materials 0
STORES, SPARES AND LOOSE TOOLS
Imported Stores And Spares 0
Indigenous Stores And Spares 0
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend 391.4
Tax On Dividend 0
Equity Dividend Rate (%) 500
aboratories
Mar/2020 Mar/2019 Mar/2018 Mar/2017
Revenue - Dr. Reddy's Labo
10,572.90 9,302.60 9,628.10 10,234.80
- Sun Pharma
0 0 0 84.2 14,000.00
10,572.90 9,302.60 9,628.10 10,150.60 12,000.00
10,625.50 9,359.30 9,719.80 10,207.70
10,000.00
238.4 204 591.2 244.8
8,000.00

In Rs. Cr.
10,863.90 9,563.30 10,311.00 10,452.50
6,000.00
2,103.20 2,011.00 1,904.60 1,988.50 4,000.00
0 0 0 94.2
2,000.00
66 -51.6 1.9 -28.8
1,931.90 1,843.00 1,803.30 1,710.00 0.00
Mar/2021 Mar/2020 M
56.8 62.8 57.2 63.8
780.6 774.1 735.1 649.1
3,356.10 3,555.40 3,592.90 3,429.40
9,163.20 8,866.30 8,766.50 8,516.60
PROFIT Dr. Reddy's V
1,700.70 697 1,544.50 1,935.90 3,500.00
0 0 0 -355.9 3,000.00
1,700.70 697 1,544.50 1,580.00 2,500.00
2,000.00
281.8 138.1 182.6 416 1,500.00

In Rs. Cr.
0 0 0 97 1,000.00
141.6 -8 -22.2 -93.5 500.00
0 0 0 0 0.00
423.4 130.1 160.4 225.5 Mar/2021 Mar/2020 M
-500.00
1,277.30 566.9 1,384.10 1,354.50
-1,000.00
1,277.30 566.9 1,384.10 1,354.50
-1,500.00
1,277.30 566.9 1,384.10 1,354.50

76.98 34.19 83.05 79.42

76.85 34.12 82.88 79.14

0 0 0 766.8
0 0 0 1,221.70

0 0 0 107
0 0 0 322.1

332 399.2 335.3 340.5

68.2 0 0 69.3
400 400 400 400
Revenue - Dr. Reddy's Laboratories Vs Revenue
- Sun Pharma
14,000.00

12,000.00

10,000.00

8,000.00
In Rs. Cr.

6,000.00

4,000.00

2,000.00

0.00
Mar/2021 Mar/2020 Mar/2019 Mar/2018 Mar/2017

PROFIT Dr. Reddy's Vs Sun Pharma

3,500.00
3,000.00
2,500.00
2,000.00
1,500.00
In Rs. Cr.

1,000.00
500.00
0.00
Mar/2021 Mar/2020 Mar/2019 Mar/2018 Mar/2017
-500.00
-1,000.00
-1,500.00
 Sun Pharma
PROFIT & LOSS ACCOUNT OF Sun Pharma (in Rs. Cr.) Mar/2021
12 mths
INCOME
REVENUE - Sun Pharma 11,906.74
Less: Excise/Sevice Tax/Other Levies 0
REVENUE FROM OPERATIONS [NET] 11,906.74
TOTAL OPERATING REVENUES 12,531.93
Other Income 1,510.92
TOTAL REVENUE 14,042.85
EXPENSES
Cost Of Materials Consumed 3,201.71
Operating And Direct Expenses 0
Changes In Inventories Of FG,WIP And Stock-In Trade 138.6
Employee Benefit Expenses 1,702.77
Finance Costs 408.01
Depreciation And Amortisation Expenses 561.56
Other Expenses 3,549.79
TOTAL EXPENSES 10,789.85
PROFIT/LOSS BEFORE EXCEPTIONAL, EXTRAORDINARY ITEMS AND TAX 3,253.00
Exceptional Items 0
PROFIT/LOSS BEFORE TAX 3,253.00
TAX EXPENSES-CONTINUED OPERATIONS
Current Tax 386.46
Less: MAT Credit Entitlement 0
Deferred Tax -344.6
Tax For Earlier Years 0
TOTAL TAX EXPENSES 41.86
PROFIT/LOSS AFTER TAX AND BEFORE EXTRAORDINARY ITEMS 3,211.14
PROFIT/LOSS FROM CONTINUING OPERATIONS 3,211.14
PROFIT - Sun Pharma 3,211.14
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.) 13.4
Diluted EPS (Rs.) 13.4
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND
LOOSE TOOLS
Imported Raw Materials 0
Indigenous Raw Materials 0
STORES, SPARES AND LOOSE TOOLS
Imported Stores And Spares 0
Indigenous Stores And Spares 0
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend 1,378.96
Tax On Dividend 192.89
Equity Dividend Rate (%) 400
ma
Mar/2020 Mar/2019 Mar/2018 Mar/2017
12 mths 12 mths 12 mths 12 mths

9,783.29 8,774.41 7,509.67 7,262.46

0 0 109.24 130.43
9,783.29 8,774.41 7,400.43 7,132.03
10,303.21 9,006.25 7,683.96 7,614.46
1,271.44 1,128.04 515.08 431.82
11,574.65 10,134.29 8,199.04 8,046.28

2,727.71 2,210.12 2,228.45 2,019.85

0 0 0 0
-251.3 159.26 -167.86 -68.48
1,571.34 1,625.00 1,499.88 1,480.51
540.92 388.31 223.57 530.64
552.95 487.24 422.28 463.98
3,302.35 2,832.10 2,773.02 3,447.56
9,640.82 8,903.54 8,215.84 9,044.06
1,933.83 1,230.75 -16.80 -997.78
-1,214.38 -950.5 0 -70.13
719.45 280.25 -16.80 -1,067.91

1.55 2.02 5.77 5.45

0 0 0 0
-98.7 -27.41 0.27 0
0 0 0 0
-97.15 -25.39 6.04 5.45
816.60 305.64 -22.84 -1,073.36
816.60 305.64 -22.84 -1,073.36
816.60 305.64 -22.84 -1,073.36

3.4 1.3 -0.1 -4.5

3.4 1.3 -0.1 -4.5

0 0 0 823.35
0 0 0 1,196.50

0 0 0 77.34
0 0 0 283.04

479.16 797.74 240.68 240.68

0.56 0.34 7.47 7.47
275 200 350 100
Company Name Price Rank Net Profit Rank Net Sales Rank Assets Rank
Dr Reddys Labs 4800.9 1 1,969 3 17,517 3 19,476 4
Sun Pharma 634.75 5 4,186 1 32,837 1 38,410 1
Divis Labs 3822.45 2 1,372 5 5,310 5 8,514 5
Cipla 847.7 4 1,546 4 17,131 4 20,406 2
Aurobindo Pharm 942.85 3 2,844 2 23,098 2 19,535 3

Last Price Net Profit

6000 4,500
4,000
5000
3,500
4000 3,000
2,500
3000
2,000
2000 1,500
1,000
1000
500
0 0
Dr Reddys Sun Pharma Divis Labs Cipla Aurobindo Dr Reddys Sun Pharma Divis Labs Cip
Labs Pharm Labs

Assets Sales Turnover

45,000 6.00
40,000
35,000 5.00
30,000 4.00
25,000
20,000 3.00
15,000 2.00
10,000
5,000 1.00
0 0.00
Dr Reddys Sun Pharma Divis Labs Cipla Aurobindo Dr Reddys Sun Pharma Divis Labs Cipla
Labs Pharm Labs
 Sales Turnover Rank
5.00 1
4.17 2
3.04 4
3.91 3
3.00 5

Net Profit Net Sales

35,000
30,000
25,000
20,000
15,000
10,000
5,000
0
Pharma Divis Labs Cipla Aurobindo Dr Reddys Sun Pharma Divis Labs Cipla Aurobindo
Pharm Labs Pharm

ales Turnover

harma Divis Labs Cipla Aurobindo

Pharm